title: APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival.
abstract: APRIL (a proliferation-inducing ligand) and BLyS (B lymphocyte stimulator) expression have been reported in chronic lymphocytic leukemia (CLL) cells. We examined APRIL and BLyS serum levels in CLL patients and evaluated the prognostic significance of APRIL expression on survival.
authors.forename: Lourdes
authors.initials: L
authors.lastname: Planelles
authors.forename: Sonia
authors.initials: S
authors.lastname: Castillo-Gutiérrez
authors.forename: Jan Paul
authors.initials: JP
authors.lastname: Medema
authors.forename: Antonio
authors.initials: A
authors.lastname: Morales-Luque
authors.forename: Hélène
authors.initials: H
authors.lastname: Merle-Béral
authors.forename: Michael
authors.initials: M
authors.lastname: Hahne
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011379:Prognosis; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*; D012189:Retrospective Studies; D015996:Survival Rate; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000097:blood*
chemical_list: C120197:BLyS receptor; D018124:Receptors, Tumor Necrosis Factor; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13